These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8106944)
21. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497 [TBL] [Abstract][Full Text] [Related]
22. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Felberbaum RE; Albano C; Ludwig M; Riethmüller-Winzen H; Grigat M; Devroey P; Diedrich K Hum Reprod; 2000 May; 15(5):1015-20. PubMed ID: 10783344 [TBL] [Abstract][Full Text] [Related]
23. Serum estradiols versus pelvic sonography in monitoring HMG therapy. Check JH; Goldberg BB; Kurtz A; Adelson HG; Dietterich C Int J Fertil; 1985; 30(2):61-3. PubMed ID: 2865227 [TBL] [Abstract][Full Text] [Related]
24. Induction of ovulation with luprolide acetate and human menopausal gonadotropin. Lewinthal D; Taylor PJ; Pattinson HA; Corenblum B Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242 [TBL] [Abstract][Full Text] [Related]
25. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). Kemeter P; Feichtinger W Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476 [No Abstract] [Full Text] [Related]
26. Induction of follicle maturation and ovulation by gonadotropin administration in women with beta-thalassemia. Danesi L; Scacchi M; Miragoli AM; Pincelli AI; Dubini A; Maiolo AT; Cavagnini F; Polli EE Eur J Endocrinol; 1994 Dec; 131(6):602-6. PubMed ID: 7804443 [TBL] [Abstract][Full Text] [Related]
27. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation. Fogel M; Rubin BL; Ossowski R Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593 [TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients. Dale PO; Tanbo T; Haug E; Abyholm T Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931 [TBL] [Abstract][Full Text] [Related]
29. Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome. Wada I; Matson PL; Troup SA; Lieberman BA J Assist Reprod Genet; 1995 Apr; 12(4):252-7. PubMed ID: 7580021 [TBL] [Abstract][Full Text] [Related]
30. Generic human menopausal gonadotropin (hMG) in place of more costly follicle-stimulating hormone (FSH) for routine ovulation induction. Gleicher N; Karande V J Assist Reprod Genet; 2000 Oct; 17(9):489-95. PubMed ID: 11155320 [TBL] [Abstract][Full Text] [Related]
31. Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: the effect of ovulation induction with menopausal gonadotropins, GH, and gestation. Blumenfeld Z; Barkey RJ; Youdim MB; Brandes JM; Amit T J Clin Endocrinol Metab; 1992 Nov; 75(5):1242-9. PubMed ID: 1430084 [TBL] [Abstract][Full Text] [Related]
32. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy. Notation AD; Tagatz GE; Steffes MW Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235 [TBL] [Abstract][Full Text] [Related]
33. Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. van der Meer S; Gerris J; Joostens M; Tas B Hum Reprod; 1993 Oct; 8(10):1628-31. PubMed ID: 8300818 [TBL] [Abstract][Full Text] [Related]
34. Ovarian follicular development stimulated by leuprorelin acetate plus human menopausal gonadotropin in chimpanzees. Yoshimoto N; Shimoda K; Mori Y; Honda R; Okamura H; Ide Y; Nakashima T; Nakagata N; Torii R; Yoshikawa Y; Hayasaka I J Med Primatol; 2005 Apr; 34(2):73-85. PubMed ID: 15860113 [TBL] [Abstract][Full Text] [Related]
35. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. Muasher SJ; Garcia JE; Rosenwaks Z Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669 [TBL] [Abstract][Full Text] [Related]
36. Ovulation induction with human menopausal gonadotrophins: an evaluation of a variable daily dosage regimen. Webb-Wilson GJ; Arronet GH Int J Fertil; 1977; 22(4):225-31. PubMed ID: 24600 [TBL] [Abstract][Full Text] [Related]
37. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth. Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087 [TBL] [Abstract][Full Text] [Related]
38. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist. Tanbo T; Dale PO; Abyholm T Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069 [TBL] [Abstract][Full Text] [Related]
39. Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Dickey RP; Olar TT; Taylor SN; Curole DN; Rye PH Hum Reprod; 1993 Jan; 8(1):56-9. PubMed ID: 8458927 [TBL] [Abstract][Full Text] [Related]
40. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT. Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]